Recce Pharmaceuticals

Recce Pharmaceuticals Dividend

Dividend of Recce Pharmaceuticals (RCE.AX) as of Nov 18, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does Recce Pharmaceuticals 2026 pay?

According to the latest status from November 2026, Recce Pharmaceuticals paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current Recce Pharmaceuticals price of 0.37 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Recce Pharmaceuticals Dividends

Historical Recce Pharmaceuticals Dividends
PaydateDividend

The Recce Pharmaceuticals Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.00 AUD
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
The Recce Pharmaceuticals Dividend history
YEARDividendYoY
est0.00AUD—
est0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the Recce Pharmaceuticals Dividend Safe?

Recce Pharmaceuticals has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Recce Pharmaceuticals's Dividend Distributions

Recce Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Recce Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Recce Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Recce Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Recce Pharmaceuticals Stock analysis

What does Recce Pharmaceuticals do? Recce Pharmaceuticals Ltd. develops pharmaceutical drugs targeting germ-killing therapies, focusing on anti-infective solutions. The company’s pipeline includes RECCE 327, an intravenous and topical therapy for serious bacterial infections including superbugs, RECCE 435 as an oral treatment for bacterial infections, and RECCE 529 for viral infections. All compounds are 100% water soluble across all pH levels in liquid form, leveraging multi-layered mechanisms to combat bacterial and viral mutations. The company operates through research and development, with no additional product lines or services mentioned. Recce Pharmaceuticals Ltd. generates revenue primarily through the development and potential commercialization of its anti-infective drugs. The target market includes healthcare providers and institutions treating serious infections, particularly those dealing with antibiotic-resistant bacteria and viral pathogens. The company’s focus on broad-spectrum synthetic polymer anti-infectives positions it for partnerships with pharmaceutical distributors and healthcare systems seeking novel treatments for life-threatening infections. The business model relies on the progression of its drug pipeline from research to clinical trials and eventual market entry. RECCE 327, RECCE 435, and RECCE 529 are the only products described, with no mention of licensing agreements, partnerships, or additional revenue streams beyond drug development and sales. The company’s financial success depends on the successful advancement of these compounds through regulatory approval processes. Recce Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Recce Pharmaceuticals stock

Recce Pharmaceuticals paid dividends every year for the past 0 years.

Recce Pharmaceuticals is assigned to the 'Health' sector.

The dividends of Recce Pharmaceuticals are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Recce Pharmaceuticals